How to integrate stereotactic body radiation therapy and hypofractionation in the management of stage III lung cancer in the age of immunotherapy

The constant advances in the field of lung cancer immunotherapy have recently reached the treatment of locally advanced disease with the approval of durvalumab after concurrent chemoradiation. However, radiation therapy continues to be key for controlling the disease at this stage. Over the years, d...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	M. Rico, S. Flamarique Andueza, A. Martín Martínez, M.A. Rodríguez Mendizábal, L. Rosas Gutiérrez, E. Martínez López
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Departamento de Salud del Gobierno de Navarra (Health Department, Goverment of Navarra) 2020-08-01
סדרה:	Anales del Sistema Sanitario de Navarra
נושאים:	Lung cancer. Hypofractionation. SBRT. Immunotherapy.
גישה מקוונת:	https://recyt.fecyt.es/index.php/ASSN/article/view/74609
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!